Exome Sequencing for Prenatal Diagnosis in Nonimmune Hydrops Fetalis
- PMID: 33027564
- PMCID: PMC7650529
- DOI: 10.1056/NEJMoa2023643
Exome Sequencing for Prenatal Diagnosis in Nonimmune Hydrops Fetalis
Abstract
Background: The cause of most fetal anomalies is not determined prenatally. Exome sequencing has transformed genetic diagnosis after birth, but its usefulness for prenatal diagnosis is still emerging. Nonimmune hydrops fetalis (NIHF), a fetal abnormality that is often lethal, has numerous genetic causes; the extent to which exome sequencing can aid in its diagnosis is unclear.
Methods: We evaluated a series of 127 consecutive unexplained cases of NIHF that were defined by the presence of fetal ascites, pleural or pericardial effusions, skin edema, cystic hygroma, increased nuchal translucency, or a combination of these conditions. The primary outcome was the diagnostic yield of exome sequencing for detecting genetic variants that were classified as either pathogenic or likely pathogenic according to the criteria of the American College of Medical Genetics and Genomics. Secondary outcomes were the percentage of cases associated with specific genetic disorders and the proportion of variants that were inherited.
Results: In 37 of the 127 cases (29%), we identified diagnostic genetic variants, including those for disorders affecting the RAS-MAPK cell-signaling pathway (known as RASopathies) (30% of the genetic diagnoses); inborn errors of metabolism and musculoskeletal disorders (11% each); lymphatic, neurodevelopmental, cardiovascular, and hematologic disorders (8% each); and others. Prognoses ranged from a relatively mild outcome to death during the perinatal period. Overall, 68% of the cases (25 of 37) with diagnostic variants were autosomal dominant (of which 12% were inherited and 88% were de novo), 27% (10 of 37) were autosomal recessive (of which 95% were inherited and 5% were de novo), 1 was inherited X-linked recessive, and 1 was of uncertain inheritance. We identified potentially diagnostic variants in an additional 12 cases.
Conclusions: In this large case series of 127 fetuses with unexplained NIHF, we identified a diagnostic genetic variant in approximately one third of the cases. (Funded by the UCSF Center for Maternal-Fetal Precision Medicine and others; ClinicalTrials.gov number, NCT03412760.).
Copyright © 2020 Massachusetts Medical Society.
Figures
Comment in
-
Nonimmune Hydrops Fetalis - More Than Meets the Eye?N Engl J Med. 2020 Oct 29;383(18):1785-1786. doi: 10.1056/NEJMe2029914. Epub 2020 Oct 7. N Engl J Med. 2020. PMID: 33027567 No abstract available.
Similar articles
-
Fetal hydrops and the Incremental yield of Next-generation sequencing over standard prenatal Diagnostic testing (FIND) study: prospective cohort study and meta-analysis.Ultrasound Obstet Gynecol. 2021 Oct;58(4):509-518. doi: 10.1002/uog.23652. Ultrasound Obstet Gynecol. 2021. PMID: 33847422 Free PMC article.
-
Exome sequencing vs targeted gene panels for the evaluation of nonimmune hydrops fetalis.Am J Obstet Gynecol. 2022 Jan;226(1):128.e1-128.e11. doi: 10.1016/j.ajog.2021.07.014. Epub 2021 Jul 28. Am J Obstet Gynecol. 2022. PMID: 34331894 Free PMC article.
-
Cost-Effectiveness of Exome Sequencing versus Targeted Gene Panels for Prenatal Diagnosis of Fetal Effusions and Non-Immune Hydrops Fetalis.Am J Obstet Gynecol MFM. 2022 Nov;4(6):100724. doi: 10.1016/j.ajogmf.2022.100724. Epub 2022 Aug 19. Am J Obstet Gynecol MFM. 2022. PMID: 35995366 Free PMC article.
-
RASopathies are the most common set of monogenic syndromes identified by exome sequencing for nonimmune hydrops fetalis: A systematic review and meta-analysis.Am J Med Genet A. 2024 May;194(5):e63494. doi: 10.1002/ajmg.a.63494. Epub 2023 Dec 29. Am J Med Genet A. 2024. PMID: 38156365 Review.
-
Identification of novel PIEZO1 variants using prenatal exome sequencing and correlation to ultrasound and autopsy findings of recurrent hydrops fetalis.Am J Med Genet A. 2018 Dec;176(12):2829-2834. doi: 10.1002/ajmg.a.40533. Epub 2018 Sep 23. Am J Med Genet A. 2018. PMID: 30244526 Review.
Cited by
-
Prenatal diagnosis of fetuses with ultrasound anomalies by whole-exome sequencing in Luoyang city, China.Front Genet. 2024 Jan 22;14:1301439. doi: 10.3389/fgene.2023.1301439. eCollection 2023. Front Genet. 2024. PMID: 38318287 Free PMC article.
-
Trust in prenatal exome sequencing for expectant families facing unexplained fetal anomalies.Prenat Diagn. 2024 Mar;44(3):263-269. doi: 10.1002/pd.6507. Epub 2023 Dec 29. Prenat Diagn. 2024. PMID: 38158591
-
A de novo homozygous missense mutation of the GUSB gene leads to mucopolysaccharidosis type VII identification in a family with twice adverse pregnancy outcomes due to non-immune hydrops fetalis.Mol Genet Metab Rep. 2023 Dec 6;38:101033. doi: 10.1016/j.ymgmr.2023.101033. eCollection 2024 Mar. Mol Genet Metab Rep. 2023. PMID: 38149215 Free PMC article.
-
Monogenic conditions and central nervous system anomalies: A prospective study, systematic review and meta-analysis.Prenat Diagn. 2024 Apr;44(4):422-431. doi: 10.1002/pd.6466. Epub 2023 Dec 6. Prenat Diagn. 2024. PMID: 38054560 Free PMC article.
-
CEP55-associated lethal fetal syndrome: a case report of a Chinese family.Front Genet. 2023 Oct 20;14:1267241. doi: 10.3389/fgene.2023.1267241. eCollection 2023. Front Genet. 2023. PMID: 37928238 Free PMC article.
References
-
- Staebler M, Donner C, Van Regemorter N, et al. Should determination of the karyotype be systematic for all malformations detected by obstetrical ultrasound? Prenat Diagn 2005;25:567–73. - PubMed
-
- American College of Obstetricians and Gynecologists Committee on Genetics. Committee opinion no. 581: the use of chromosomal microarray analysis in prenatal diagnosis. Obstet Gynecol 2013;122:1374–7. - PubMed
Publication types
MeSH terms
Associated data
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases